TABLE 3.
Prevalence | N0 | N1 | Sp | Se | NPV | PPV | |
---|---|---|---|---|---|---|---|
1 | 0.216 | 91 | 25 | 0.725 | 0.600 | 0.957 | 0.938 |
2 | 0.223 | 94 | 27 | 0.628 | 0.444 | 0.967 | 0.545 |
3 | 0.283 | 198 | 78 | 0.717 | 0.692 | 0.993 | 0.885 |
4 | 0.293 | 256 | 106 | 0.656 | 0.623 | 0.908 | 0.868 |
5 | 0.298 | 139 | 59 | 0.748 | 0.508 | 0.929 | 0.811 |
6 | 0.325 | 129 | 62 | 0.721 | 0.581 | 0.912 | 0.923 |
7 | 0.330 | 77 | 38 | 0.636 | 0.632 | 0.891 | 0.857 |
8 | 0.364 | 49 | 28 | 0.980 | 0.286 | 0.814 | 1.000 |
9 | 0.369 | 123 | 72 | 0.504 | 0.694 | 0.984 | 0.735 |
10 | 0.371 | 107 | 63 | 0.701 | 0.603 | 0.938 | 0.927 |
11 | 0.373 | 151 | 90 | 0.543 | 0.589 | 0.891 | 0.736 |
12 | 0.375 | 70 | 42 | 0.729 | 0.357 | 0.836 | 0.882 |
13 | 0.429 | 20 | 15 | 0.400 | 0.867 | 1.000 | 0.684 |
14 | 0.450 | 105 | 86 | 0.505 | 0.570 | 0.898 | 0.790 |
15 | 0.465 | 76 | 66 | 0.553 | 0.667 | 0.933 | 0.936 |
16 | 0.478 | 93 | 85 | 0.570 | 0.659 | 0.898 | 0.949 |
17 | 0.543 | 37 | 44 | 0.838 | 0.341 | 0.738 | 1.000 |
18 | 0.561 | 43 | 55 | 0.884 | 0.582 | 0.826 | 1.000 |
19 | 0.620 | 68 | 111 | 0.574 | 0.766 | 0.907 | 0.955 |
20 | 0.620 | 30 | 49 | 0.767 | 0.653 | 0.767 | 0.970 |
21 | 0.622 | 96 | 158 | 0.615 | 0.715 | 0.819 | 0.904 |
22 | 0.635 | 38 | 66 | 0.737 | 0.712 | 0.824 | 1.000 |
23 | 0.733 | 40 | 110 | 0.800 | 0.645 | 0.744 | 0.986 |
24 | 0.737 | 31 | 87 | 0.613 | 0.494 | 0.633 | 0.977 |
25 | 0.762 | 35 | 112 | 0.743 | 0.741 | 0.963 | 0.954 |
26 | 0.765 | 43 | 140 | 0.767 | 0.436 | 0.541 | 0.968 |
27 | 0.821 | 63 | 288 | 0.873 | 0.597 | 0.611 | 0.983 |
28 | 0.825 | 7 | 33 | 0.857 | 0.364 | 0.500 | 1.000 |
29 | 0.849 | 21 | 118 | 0.429 | 0.508 | 0.346 | 0.984 |
30 | 0.870 | 49 | 327 | 0.878 | 0.722 | 0.632 | 1.000 |
N0, N1: sizes of the samples of patients without and with CI.
NPV indicates negative predictive value; PPV, positive predictive value; Se, sensitivity; Sp, specificity.